Expertise in
14
conditions

Martin H. Ellis

Tel Aviv, TA, IL 
Expertise in
14
conditions
Tel Aviv, TA, IL 

Overview

Martin Ellis practices practicing medicine in Tel Aviv, Israel.

Mr. Ellis is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Hemophagocytic Lymphohistiocytosis, Polycythemia Vera, and Non-Langerhans-Cell Histiocytosis.

He is actively involved in clinical research, co-authoring 117 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Tel Aviv, TA, Israel
Other Locations
Kfar Saba, M, Israel
Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2, Multicenter, Non-Randomized, Open-Label Study of RVT-1401 for the Treatment of Patients With Warm Autoimmune Hemolytic Anemia
A Phase 2, Multicenter, Non-Randomized, Open-Label Study of RVT-1401 for the Treatment of Patients With Warm Autoimmune Hemolytic Anemia
Enrollment Status: Terminated
Publish Date: July 28, 2022
Intervention Type: Drug
Study Phase: Phase 2
Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
Enrollment Status: Completed
Publish Date: December 06, 2019
Intervention Type: Other
The Effect of Active Adherence-Encouraging Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - A Prospective Observational Multicenter Study (TAKE-IT)
The Effect of Active Adherence-Encouraging Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - A Prospective Observational Multicenter Study (TAKE-IT)
Enrollment Status: Completed
Publish Date: June 07, 2017
Intervention Type: Behavioral
Study Phase: Not Applicable
View 2 Less Clinical Trials

117 Total Publications

Abdominal Pain as the First Manifestation of Rare Hematological Diseases: A Case Series
Abdominal Pain as the First Manifestation of Rare Hematological Diseases: A Case Series
Journal: Harefuah
Published: September 03, 2026

Frequently Asked Questions about Martin H. Ellis

Is Martin H. Ellis a top-rated expert for Myeloproliferative Neoplasms (MPN)?

MediFind is an objective health platform that identifies experts based on real-world data. Martin H. Ellis is classified as an Distinguished expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin H. Ellis participate in research or clinical trials?

Yes. Martin H. Ellis has published 117 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Martin H. Ellis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ellis's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile